Free Trial
LON:PXS

Provexis Interim Earnings Results & Report

GBX 0.90 +0.10 (+11.80%)
As of 12:25 PM Eastern

Provexis reported Interim earnings on December 31, 2025. The company reported EPS of -GBX 0.01.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

Provexis EPS Results

Actual EPS
-GBX 0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Provexis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Provexis Interim Earnings FAQ

Provexis (LON:PXS) reported earnings of -GBX 0.01 per share for Interim. The report was announced on Wednesday, December 31, 2025.

Provexis Earnings Headlines

Provexis (PXS) AI Stock Analysis
Provexis PLC Full Year Sales Decline
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
AIM Market Roundup: Ramsdens, Provexis, Pulsar Helium
AIM Market Roundup: Provexis, Geo Exploration, Sabien
See More Provexis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Provexis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Provexis and other key companies, straight to your email.

About Provexis

Provexis (LON:PXS), together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

View Provexis Profile